Clinical trial of KD-FLU in healthy children

Status

Unknown

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080221413

Enrollment

Registered

2011-03-25

Start date

2011-03-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prophylaxis of influenza infection

Interventions

investigational material(s) Generic name etc : KD-FLU(trivalent inactivated influenza vaccine) INN of investigational material : Therapeutic category code : 631 Vaccines Dosage and Administration for

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy childeren

Exclusion criteria

Exclusion criteria: Known history of influenza or received influenza vaccination within six months.

Design outcomes

Primary

Measure	Time frame
Immunogenicity HI antibody titer against antigens	—

Secondary

Measure	Time frame
Immunogenicity Neutralizing antibody titer against influenza viruses	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026